blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3509599

EP3509599 - 1,2-DITHIOLANE COMPOUNDS USEFUL IN NEUROPROTECTION, AUTOIMMUNE AND CANCER DISEASES AND CONDITIONS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  26.07.2024
Database last updated on 05.10.2024
FormerExamination is in progress
Status updated on  11.03.2022
FormerRequest for examination was made
Status updated on  14.06.2019
FormerThe international publication has been made
Status updated on  23.03.2018
Most recent event   Tooltip26.07.2024Application deemed to be withdrawnpublished on 28.08.2024  [2024/35]
Applicant(s)For all designated states
Sabila Biosciences LLC
5 Overlook Road
New City, NY 10956 / US
[2019/29]
Inventor(s)01 / MANSOUR, Tarek, S.
5 Overlook Road
New City NY 10956 / US
02 / EVANS, Collen, E.
5 Overlook Road
New City NY 10956 / US
 [2019/29]
Representative(s)Schnappauf, Georg
ZSP Patentanwälte PartG mbB
Hansastraße 32
80686 München / DE
[2019/29]
Application number, filing date17849588.308.09.2017
[2019/29]
WO2017US50634
Priority number, dateUS201662384813P08.09.2016         Original published format: US 201662384813 P
[2019/29]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018049127
Date:15.03.2018
Language:EN
[2018/11]
Type: A1 Application with search report 
No.:EP3509599
Date:17.07.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 15.03.2018 takes the place of the publication of the European patent application.
[2019/29]
Search report(s)International search report - published on:US15.03.2018
(Supplementary) European search report - dispatched on:EP17.01.2020
ClassificationIPC:A61K31/519, A61K31/4162, C07D339/04, A61K45/06, A61P35/00, C07D487/04
[2020/08]
CPC:
A61P35/00 (EP); C07D339/04 (US); A61K31/519 (EP);
A61K45/06 (EP); C07C43/29 (US); C07D487/04 (EP,US);
C07F5/025 (US); C07F7/1804 (US) (-)
Former IPC [2019/29]A61K31/519, A61K31/4162, C07D339/04
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/29]
Validation statesMA13.03.2019
TitleGerman:1,2-DITHIOLAN-VERBINDUNGEN FÜR DIE NEUROPROTEKTION, AUTOIMMUN- UND KREBSERKRANKUNGEN UND -LEIDEN[2019/29]
English:1,2-DITHIOLANE COMPOUNDS USEFUL IN NEUROPROTECTION, AUTOIMMUNE AND CANCER DISEASES AND CONDITIONS[2019/29]
French:COMPOSÉS 1,2-DITHIOLANE UTILES DANS LA NEUROPROTECTION, LES MALADIES ET LES ÉTATS AUTO-IMMUNS ET CANCÉREUX[2019/29]
Entry into regional phase13.03.2019National basic fee paid 
13.03.2019Search fee paid 
13.03.2019Designation fee(s) paid 
13.03.2019Examination fee paid 
Examination procedure13.03.2019Examination requested  [2019/29]
05.08.2020Amendment by applicant (claims and/or description)
11.03.2022Despatch of a communication from the examining division (Time limit: M06)
14.09.2022Reply to a communication from the examining division
03.04.2024Application deemed to be withdrawn, date of legal effect  [2024/35]
23.04.2024Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2024/35]
Fees paidRenewal fee
06.09.2019Renewal fee patent year 03
10.09.2020Renewal fee patent year 04
08.09.2021Renewal fee patent year 05
08.09.2022Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
30.09.202307   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2008121742  (PHARMACYCLICS INC [US], et al) [A] 1-15* claims 1-100; compounds 11, 13-15 *
International search[A]US2010184760  (REN PINGDA [US], et al) [A] 1-23 * para [0035], [0396], [0689]; pg 127, compound 5 *;
 [A]WO2011141909  (RADIKAL THERAPEUTICS INC [US], et al) [A] 1-23 * pg 2, para 3-4; pg 3, para 4 to pg 5, para 1; pg 20, Table 2, compound 2; pg 32, para 4 to pg 33, para 1; pg 34-35, Schemes 1, 2 and 3 *;
 [A]US8795706  (GARNER WILLIAM [US], et al) [A] 1-23 * col 18-22, Table 2; Table 3; Table 4; Table 5; col 24, In 24-45; col 31, In 20 to col 34, In 20 *;
 [A]US2015018336  (CHEN WEI [US], et al) [A] 1-23 * para [0005]; pg 108, Example 79; Example 80; pg 109, Example 82; pg 112, Example 85h; para [0416]-[0417] *;
 [A]US2015284478  (AGAR JEFFREY N [US], et al) [A] 1-23* Entire Document *;
 [A]  - HOMHUAL et al., "Bruguiesulfurol, A new Sulfur Compound from Bruguiera gymnorrhiza", Planta Med., (20060000), vol. 72, no. 4, pages 255 - 260, XP018019704 [A] 1-23 * . abstract; pg 256, col 1, para 1; pg 259, col 1, para 2-3; Table 2 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.